IN2014DN07019A - - Google Patents
Info
- Publication number
- IN2014DN07019A IN2014DN07019A IN7019DEN2014A IN2014DN07019A IN 2014DN07019 A IN2014DN07019 A IN 2014DN07019A IN 7019DEN2014 A IN7019DEN2014 A IN 7019DEN2014A IN 2014DN07019 A IN2014DN07019 A IN 2014DN07019A
- Authority
- IN
- India
- Prior art keywords
- positive
- methods
- cancer
- mammalian subject
- diagnosing
- Prior art date
Links
- 238000000034 method Methods 0.000 abstract 3
- 206010028980 Neoplasm Diseases 0.000 abstract 2
- 201000011510 cancer Diseases 0.000 abstract 2
- 208000005443 Circulating Neoplastic Cells Diseases 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 208000037819 metastatic cancer Diseases 0.000 abstract 1
- 208000011575 metastatic malignant neoplasm Diseases 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57492—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds localized on the membrane of tumor or cancer cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
- G01N33/533—Production of labelled immunochemicals with fluorescent label
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70589—CD45
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Hospice & Palliative Care (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Sampling And Sample Adjustment (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261590066P | 2012-01-24 | 2012-01-24 | |
| US201361753665P | 2013-01-17 | 2013-01-17 | |
| PCT/IB2013/050547 WO2013111054A1 (en) | 2012-01-24 | 2013-01-22 | Methods for detecting 5t4-positive circulating tumor cells and methods of diagnosis of 5t4-positive cancer in a mammalian subject |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014DN07019A true IN2014DN07019A (enrdf_load_stackoverflow) | 2015-04-10 |
Family
ID=47844410
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN7019DEN2014 IN2014DN07019A (enrdf_load_stackoverflow) | 2012-01-24 | 2013-01-22 |
Country Status (14)
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2803804B2 (ja) | 1992-08-21 | 1998-09-24 | 株式会社長澤製作所 | ボタン錠 |
| CN115060882A (zh) | 2009-10-21 | 2022-09-16 | 斯克里普斯研究所 | 用非稀有细胞检测稀有细胞的方法 |
| US8956859B1 (en) | 2010-08-13 | 2015-02-17 | Aviex Technologies Llc | Compositions and methods for determining successful immunization by one or more vaccines |
| EP3090264B1 (en) * | 2013-12-30 | 2020-02-12 | The Scripps Research Institute | Circulating tumor cell diagnostics for lung cancer |
| US10527624B2 (en) | 2014-01-27 | 2020-01-07 | Epic Sciences, Inc. | Circulating tumor cell diagnostics for prostate cancer biomarkers |
| US10545151B2 (en) * | 2014-02-21 | 2020-01-28 | Epic Sciences, Inc. | Methods for analyzing rare circulating cells |
| WO2015155345A1 (en) * | 2014-04-11 | 2015-10-15 | Medimmune Limited | Antibodies and antibody-drug conjugates |
| EA201692223A1 (ru) * | 2014-05-09 | 2017-04-28 | Дзе Скриппс Рисерч Инститьют | Композиции и способы жидкостной биопсии меланомы |
| JP6657509B2 (ja) * | 2014-08-25 | 2020-03-04 | クリエイティブ マイクロテック インコーポレイテッドＣｒｅａｔｖ Ｍｉｃｒｏｔｅｃｈ， Ｉｎｃ． | 疾患の検出及び診断のための血液中の循環細胞バイオマーカーの使用並びにそれらを単離する方法 |
| CN108064343B (zh) * | 2015-04-21 | 2021-07-09 | 基因泰克公司 | 用于前列腺癌分析的组合物和方法 |
| EP3371594A1 (en) * | 2015-11-06 | 2018-09-12 | Ventana Medical Systems, Inc. | Representative diagnostics |
| KR102045069B1 (ko) * | 2016-02-23 | 2019-11-15 | 노을 주식회사 | 패치를 이용하는 ctc 진단 방법 및 장치 |
| KR102406596B1 (ko) * | 2016-02-23 | 2022-06-10 | 노을 주식회사 | 패치를 이용하는 ctc 진단 방법 및 장치 |
| KR102478639B1 (ko) | 2016-02-23 | 2022-12-19 | 노을 주식회사 | 표지 물질을 저장하는 패치, 이를 이용하는 조직 진단 방법 및 장치 |
| US10371610B2 (en) | 2016-02-23 | 2019-08-06 | Noul Co., Ltd. | Contact-type patch, staining method using the same, and manufacturing method thereof |
| KR20170099737A (ko) | 2016-02-23 | 2017-09-01 | 노을 주식회사 | 접촉식 염색 패치 및 이를 이용하는 염색 방법 |
| CA3055132A1 (en) | 2017-04-03 | 2018-10-11 | F. Hoffmann-La Roche Ag | Antibodies binding to steap-1 |
| US20210018441A1 (en) * | 2017-06-27 | 2021-01-21 | Qcdx, Llc | Quantitative liquid biopsy diagnostic system and methods |
| CN107918013A (zh) * | 2017-09-25 | 2018-04-17 | 浙江天科高新技术发展有限公司 | 化学发光酶免测定循环肿瘤细胞中K‑Ras蛋白的方法及试剂盒 |
| JP7678424B2 (ja) | 2018-05-10 | 2025-05-16 | 学校法人順天堂 | 画像解析方法、装置、コンピュータプログラム、及び深層学習アルゴリズムの生成方法 |
| US20220002429A1 (en) * | 2018-10-24 | 2022-01-06 | Northwestern University | Tumor cell aggregation inhibitors' for treating cancer |
| JP7381003B2 (ja) * | 2019-04-26 | 2023-11-15 | 学校法人順天堂 | 疾患解析を支援する方法、装置、及びコンピュータプログラム、並びにコンピュータアルゴリズムを訓練する方法、装置、及びプログラム |
| US20230175073A1 (en) | 2021-12-07 | 2023-06-08 | Epic Sciences, Inc. | Enhanced characterization of breast cancer |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4391904A (en) | 1979-12-26 | 1983-07-05 | Syva Company | Test strip kits in immunoassays and compositions therein |
| EP0403559A1 (en) | 1988-03-04 | 1990-12-27 | Cancer Research Campaign Technology Limited | Improvements relating to antigens |
| US5869053A (en) | 1988-03-04 | 1999-02-09 | Cancer Research Campaign Technology, Ltd. | 5T4 antigen from human trophoblasts |
| DK1012259T3 (da) | 1997-06-04 | 2010-01-18 | Oxford Biomedica Ltd | Tumorrettet vektor |
| AU1290001A (en) | 1999-11-18 | 2001-05-30 | Oxford Biomedica (Uk) Limited | Antibodies |
| GB0126378D0 (en) | 2001-11-02 | 2002-01-02 | Oxford Biomedica Ltd | Antigen |
| US7305112B2 (en) | 2002-10-15 | 2007-12-04 | The Scripps Research Institute | Method of converting rare cell scanner image coordinates to microscope coordinates using reticle marks on a sample media |
| SV2007002227A (es) * | 2004-09-10 | 2007-03-20 | Wyeth Corp | Anticuerpos anti-5t4 humanizados y conjugados anticuerpo anti-5t4/calicheamicina ref. 040000-0317637 |
| US20090317836A1 (en) | 2006-01-30 | 2009-12-24 | The Scripps Research Institute | Methods for Detection of Circulating Tumor Cells and Methods of Diagnosis of Cancer in Mammalian Subject |
| PA8718601A1 (es) | 2006-03-10 | 2009-05-15 | Wyeth Corp | Anticuerpos anti-5t4 y sus usos |
| US20100233693A1 (en) | 2007-04-16 | 2010-09-16 | On-O-ity, Inc | Methods for diagnosing, prognosing, or theranosing a condition using rare cells |
| GB0822836D0 (en) * | 2008-12-15 | 2009-01-21 | Oxford Biomedica Ltd | Method |
| CA2756493C (en) | 2009-03-24 | 2019-07-02 | Biocept, Inc. | Devices and methods of cell capture and analysis |
| EP2411508B1 (en) | 2009-03-27 | 2013-03-20 | Wyeth LLC | Tumor-initiating cells and methods for using same |
| AU2010289448A1 (en) | 2009-09-03 | 2012-03-22 | The Scripps Research Institute | Method for categorizing circulating tumor cells |
| CN115060882A (zh) | 2009-10-21 | 2022-09-16 | 斯克里普斯研究所 | 用非稀有细胞检测稀有细胞的方法 |
| US9469876B2 (en) * | 2010-04-06 | 2016-10-18 | Caris Life Sciences Switzerland Holdings Gmbh | Circulating biomarkers for metastatic prostate cancer |
| RU2550925C2 (ru) | 2010-07-07 | 2015-05-20 | Зе Реджентс Оф Зе Юниверсити Оф Мичиган | Диагностика и лечение рака молочной железы |
| ES2596194T3 (es) | 2011-04-01 | 2017-01-05 | Wyeth Llc | Conjugados de anticuerpo-fármaco |
-
2013
- 2013-01-22 AU AU2013213301A patent/AU2013213301A1/en not_active Abandoned
- 2013-01-22 KR KR1020147020394A patent/KR101716555B1/ko not_active Expired - Fee Related
- 2013-01-22 US US14/374,083 patent/US10254286B2/en not_active Expired - Fee Related
- 2013-01-22 MX MX2014008928A patent/MX361058B/es active IP Right Grant
- 2013-01-22 JP JP2014553836A patent/JP6254951B2/ja not_active Expired - Fee Related
- 2013-01-22 EP EP13708526.2A patent/EP2807485B1/en active Active
- 2013-01-22 CA CA2861437A patent/CA2861437C/en not_active Expired - Fee Related
- 2013-01-22 BR BR112014018192A patent/BR112014018192A8/pt not_active Application Discontinuation
- 2013-01-22 IN IN7019DEN2014 patent/IN2014DN07019A/en unknown
- 2013-01-22 ES ES13708526T patent/ES2724232T3/es active Active
- 2013-01-22 WO PCT/IB2013/050547 patent/WO2013111054A1/en active Application Filing
- 2013-01-22 RU RU2014127474A patent/RU2646498C2/ru active
- 2013-01-22 CN CN201380006333.9A patent/CN104094116B/zh not_active Expired - Fee Related
-
2014
- 2014-07-07 IL IL233543A patent/IL233543B/en active IP Right Grant
-
2018
- 2018-08-24 AU AU2018220154A patent/AU2018220154A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP2807485B1 (en) | 2019-03-13 |
| IL233543B (en) | 2018-02-28 |
| RU2014127474A (ru) | 2016-03-20 |
| RU2646498C2 (ru) | 2018-03-05 |
| KR101716555B1 (ko) | 2017-03-14 |
| US10254286B2 (en) | 2019-04-09 |
| BR112014018192A8 (pt) | 2021-03-02 |
| ES2724232T3 (es) | 2019-09-09 |
| AU2013213301A1 (en) | 2014-07-17 |
| MX2014008928A (es) | 2014-10-24 |
| CA2861437C (en) | 2018-08-21 |
| CN104094116A (zh) | 2014-10-08 |
| AU2018220154A1 (en) | 2018-09-13 |
| US20150017661A1 (en) | 2015-01-15 |
| MX361058B (es) | 2018-11-23 |
| JP6254951B2 (ja) | 2017-12-27 |
| EP2807485A1 (en) | 2014-12-03 |
| IL233543A0 (en) | 2014-08-31 |
| CN104094116B (zh) | 2017-05-31 |
| HK1202923A1 (en) | 2015-10-09 |
| WO2013111054A1 (en) | 2013-08-01 |
| JP2015507190A (ja) | 2015-03-05 |
| CA2861437A1 (en) | 2013-08-01 |
| KR20140100580A (ko) | 2014-08-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2014DN07019A (enrdf_load_stackoverflow) | ||
| IL225646A0 (en) | Methods and kits for detecting cancer cells in the circulation of pancreatic patients using polyspecific capture and cocktail detection reagents | |
| MX2013000917A (es) | Metodos para detectar las enfermedades o condiciones usando celulas fagociticas. | |
| TN2013000358A1 (en) | Fgfr and ligands thereof as biomarkers for breast cancer in hr positive subjects | |
| GB2545361A (en) | Protein biomarker panels for detecting colorectal cancer and advanced adenoma | |
| EP2524059A4 (en) | DETECTION OF GASTROINTESTINAL DISEASES | |
| MX2013002084A (es) | Biomarcadores y metodos de tratamiento. | |
| GB2519906A (en) | Methods and systems for detecting biological components | |
| MY197809A (en) | Biomarkers and methods of treating pd-1 and pd-l1 related conditions | |
| MY170983A (en) | Biomarker assays for detecting or measuring inhibition of tor kinase activity | |
| WO2013138522A3 (en) | Methods for assessing effectiveness and monitoring oncolytic virus treatment | |
| PH12014500063A1 (en) | Methods and nucleic acids for determining the prognosis of a cancer subject | |
| GB2531881A (en) | Method of isolating circulating tumor cells | |
| GB201015765D0 (en) | Use of myeloid cell biomarkers for the diagnosis of cancer | |
| EP4219765A3 (en) | Prostate cancer prognosis using biomarkers | |
| WO2012135844A3 (en) | Circulating exosomes as diagnostic/prognostic indicators and therapeutic targets of melanoma and other cancers | |
| WO2013036543A3 (en) | Molecular imaging of cancer cells in vivo | |
| EP2833149A4 (en) | METHOD FOR DETECTING THE MALIGNANCE DEGREE OF A CIRCULATING TUMOR CELL UNIT AND KIT THEREFOR | |
| WO2014078468A3 (en) | Biomarkers for predicting clinical response of cancer patients to treatment with immunotherapeutic agent | |
| NZ629555A (en) | Monocyte biomarkers for cancer detection | |
| EP3099821A4 (en) | Circulating tumor cell diagnostics for detection of neuroendocrine prostate cancer (nepc) | |
| WO2012012694A3 (en) | Methods of detecting autoimmune or immune-related diseases or conditions | |
| EP3385717A3 (en) | Methods of detecting prostate cancer | |
| MA40636A (fr) | Procédés pour détecter le cancer de la prostate | |
| WO2013081645A3 (en) | Erbb3 mutations in cancer |